Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
about
Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitalsFluoroquinolone-Resistant Enteric Bacteria in Sub-Saharan Africa: Clones, Implications and Research NeedsCommunity-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae.Evaluation of the ability of four ESBL-screening media to detect ESBL-producing Salmonella and ShigellaAntimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.Epidemiology and characteristics of urinary tract infections in children and adolescents.Multidrug-Resistant and Extended Spectrum Beta-Lactamase-Producing Escherichia coli in Dutch Surface Water and WastewaterDistribution, Numbers, and Diversity of ESBL-Producing E. coli in the Poultry Farm Environment.Pathogenic Escherichia coli producing Extended-Spectrum β-Lactamases isolated from surface water and wastewaterFecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study.Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in IranTravelers Can Import Colistin-Resistant Enterobacteriaceae, Including Those Possessing the Plasmid-Mediated mcr-1 Gene.Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.Exploring the feasibility and synergistic value of the One Health approach in clinical research: protocol for a prospective observational study of diagnostic pathways in human and canine patients with suspected urinary tract infection.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community levelFecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca.High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.Intense pre-admission carriage and further acquisition of ESBL-producing Enterobacteriaceae among patients and their caregivers in a tertiary hospital in Rwanda.Chromobacterium violaceum Septicaemia and Urinary Tract Infection: Case Reports from a Tertiary Care Hospital in South India.Guidelines for the prevention of travel-associated illness in older adults.Extended-spectrum β-lactamase-producing Enterobacteriaceae among pregnant women in Norway: prevalence and maternal-neonatal transmission.Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London.Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice.Biofilm growth has a threshold response to glucose in vitro.Antimicrobial Susceptibilities of Enterobacteriaceae in Community-Acquired Urinary Tract Infections during a 5-year Period: A Single Hospital Study in Korea.A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location.Urinary tract infection in diabetes: epidemiologic considerations.Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.
P2860
Q26749161-54F1F981-29F1-4692-BEC6-C942A2C419A6Q26752573-0A921809-3DC6-431D-A8FA-DA8BA6819F65Q30358381-70FB18A9-E1E7-4367-BED4-F38E9BB9A672Q30379659-9DB25F5D-AB3D-4069-B90A-7FD860DACF41Q34079113-A7AF1C0C-3ED4-4BD7-9977-2EC22E0988CAQ34157171-412E0A16-8666-428B-B9DD-E51B92FF2C5AQ35135491-3F7450CF-723C-4D70-A065-C9D714640020Q35168939-E8AA7B0E-A4BA-44DF-AFE4-2845EBAC3F5FQ35644344-FCD5B57B-F261-4DE8-8F9D-BFC2FA4C1E9DQ35648493-5E837369-824E-44C2-B78B-322C6DA1CFADQ35952418-728DE3BA-7746-456D-AA72-D24A157208DDQ36099804-3FEA87D5-1BE4-4962-AE0A-1EA02DFFE315Q36299441-ECF68545-B262-41D7-9C7B-6B6A163ED619Q36366391-6190DFC7-2B27-49F1-BF10-0E4EFC36DF84Q37120219-14BE33BE-296B-4CAE-B1A3-FBE0B2B0E7D6Q37196254-2A3ED1A0-C878-46ED-B405-89CAAB21E54CQ37205420-F6220441-EB60-4EB6-8890-7687311D05ADQ37484304-4D725461-5DCE-4526-9C3C-F45CDF888582Q37498281-A2599940-86D6-4FD3-92F8-E37C840AD6D2Q38497797-E6EF979C-9061-444E-9784-329F3197546DQ38682282-9EF6D799-F5F3-44FD-AA92-F786DAD2DBE5Q38776963-324193D0-4C05-49CD-B5E5-FCC79B2C9AA6Q38893310-6C6DD6EA-9962-4082-B7A0-3F2645891420Q38994294-06E1A310-806B-4668-A69D-CE069C637075Q39115580-C6DA84DB-C962-42AE-92B6-BBDD9456D1BEQ39119558-60AB4769-3A8B-405F-8D96-46E112103C5CQ40061282-358AC50D-7A5B-440A-9611-5774F034B961Q40386623-A662B832-4FF8-49FA-A39C-6D21BA3658C1Q40833352-BCE23816-BB8C-4017-B559-709A8E10FF6CQ40927633-EBDF83EA-869A-46A3-BD5D-A80F5A8E0DC4Q42186570-497C462F-E788-4DF0-928D-7001A661B5DDQ42366693-3070AC00-1781-4CB8-85AA-A58A4C598529Q42685344-D1706658-F9C3-4128-9738-EBD4E1BB5BE1Q43528060-F8B8E785-766A-46CB-A5C4-B3227FCEC9EFQ47284987-DC3FD012-1592-4A06-B6BF-14B45A21409C
P2860
Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk factors for community-acq ...... y in a low prevalence country.
@ast
Risk factors for community-acq ...... y in a low prevalence country.
@en
Risk factors for community-acq ...... y in a low prevalence country.
@nl
type
label
Risk factors for community-acq ...... y in a low prevalence country.
@ast
Risk factors for community-acq ...... y in a low prevalence country.
@en
Risk factors for community-acq ...... y in a low prevalence country.
@nl
prefLabel
Risk factors for community-acq ...... y in a low prevalence country.
@ast
Risk factors for community-acq ...... y in a low prevalence country.
@en
Risk factors for community-acq ...... y in a low prevalence country.
@nl
P2093
P2860
P1433
P1476
Risk factors for community-acq ...... y in a low prevalence country.
@en
P2093
Arne Søraas
Cathrine Brunborg
Irene Sandven
Pål A Jenum
P2860
P304
P356
10.1371/JOURNAL.PONE.0069581
P407
P577
2013-07-23T00:00:00Z